Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
dYdX introduces perpetual contracts for XRP and other tokens
Post Content Post Views: 77
Julius Baer stock tumbles amid loan exposure concerns
Post Content Post Views: 83
China’s Nio teams up with Geely on battery swapping projects – media
Post Content Post Views: 83
Ousted OpenAI head Sam Altman to lead Microsoft’s new AI team
Former OpenAI CEO Sam Altman will be joining Microsoft to lead a new advanced AI research team, according to Microsoft CEO Satya Nadella. Post Views: 94
Pro Research: Wall Street eyes Oracle’s cloud growth amid AI surge
Post Content Post Views: 77
Oil little changed as OPEC+ decision awaits, Black Sea storm disrupts supply
Post Content Post Views: 69